logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
delete
arrow
返回
F

Fatih Selçukbırıcık

koc university hospital

19H指数
186论文数
2.4K被引数
收录论文 37
发表时间
logo
Triggering receptors expressed on myeloid cells (TREM-1) and TREM-2 as predictors of pathological complete response to neoadjuvant therapy in triple-negative breast cancer髓系细胞表达触发受体（TREM-1）和TREM-2作为三阴性乳腺癌新辅助治疗病理完全缓解的预测因子
errBreast Cancer
IF2.9
err2026-09-21
err0
errOAAI
errNazan Demir; İvo Gökmen; Duygu Bayır Garbioğlu; Ebru Taştekin; Emre Işık; Erkan Özcan; Bülent Erdoğan; Sernaz Topaloğlu; Bahadır Köylü; Cevat İlteriş Kıkılı; Fatih Kemik; İrfan Çiçin; Fatih Selçukbiricik; Muhammet Bekir Hacıoğlu
err分享
err收藏
Clinicopathologic Features of NRG1 Fusion-Positive Non-Small Cell Lung CancerNRG1融合阳性非小细胞肺癌的临床病理特征
errGENES CHROMOSOMES & CANCER
IF2.8
err2026-09-21
err0
PREAI
errBahadır Köylü; Nur İlayda Genç; Mehmet Haluk Yücel; Anıl Yıldız; Esra Aşık; Cevat İlteriş Kıkılı; Fatih Kemik; Nazan Demir; Pınar Bulutay; Ömer Fatih Ölmez; Fatih Selçukbiricik
err分享
err收藏
Prognostic factors in avelumab maintenance therapy for metastatic urothelial carcinomaavelumab维持治疗转移性尿路上皮癌的预后因素
errImmunotherapy
IF2.3
err2026-09-02
err0
PREAI
errCaner Kapar; Oğuzcan Özkan; Eda Eylemer Mocan; Sendag Yaslikaya; Ali Murat Tatlı; Goncagül Akdağ; Hacer Demir; Irem Bilgetekin; Kaan Helvacı; Fatih Selcukbiricik; Fatih Köse; Murat Sari; Gökmen Umut Erdem; Zehra Sucuoğlu İşleyen; Cagatay Arslan; Sinemis Celik; Türkkan Evrensel; Bekir Mert Durukan; Seher Nazli Kazaz; Banu Ozturk; Halil Çelik; Miraç Özen; Pınar Erel; Pervin Can Şancı; Yakup Ergün; Hakan Taban; Ömer Faruk Kuzu; Burcu Ulaş Kahya; Ahmet Melih Arslan; Abdullah Sakin; Murat Araz; Kerem Okutur; Fahri Akgül; Cem Mirili; Alper Sevinç; Fatih Atalah; Yakup Düzköprü; Burcu Gülbağcı; Nurten Kandemir; Hakan Kosku; Esra Aydın; Dilek Erdem; Murad Guliyev; Mesut Yılmaz; Yaşar Çulha; Berksoy Şahin; Pınar Gürsoy; Mustafa Erman; Yüksel Ürün; Deniz Tural
err分享
err收藏
The Clinical Significance of Gallium-68 PSMA-11 PET-Derived SUVmax in the Management of Metastatic Hormone-Sensitive Prostate Cancer68Ga-PSMA-11 PET衍生的SUVmax在转移性激素敏感型前列腺癌管理中的临床意义
errThe Prostate
IF0
err2026-04-22
err0
errOAAI
errCevat İlteriş Kıkılı; Caner Kapar; Feyyaz Hazar Yağmur; Esra Arslan; Bahadır Köylü; Fatih Kemik; Buğra Han Esen; Nazan Demir; İlkay Gültürk; Murat Polat; Fatih Selçukbiricik; Deniz Tural
err分享
err收藏
Molecular Profiling and Survival Outcomes in Pancreatic Ductal Adenocarcinoma: A Multicenter Real-World Study from Turkey胰腺导管腺癌的分子特征分析及生存结局：一项来自土耳其的多中心真实世界研究
errCurrent Oncology
IF3.4
err2026-04-15
err0
errOAAI
errSelami Bayram; Bahadır Köylü; Maral Martin Mıldanoğlu; Mustafa Serkan Alemdar; Tahir Yerlikaya; Fatih Selçukbiricik; Ahmet Bilici; Ali Murat Tatli; Mustafa Ozdogan
err分享
err收藏
Real-world effectiveness and safety of brigatinib in advanced ALK-positive NSCLC: a nationwide multicenter study by the Turkish Oncology Groupbrigatinib 在晚期ALK阳性NSCLC中的真实世界有效性与安全性：土耳其肿瘤学组进行的一项全国多中心研究
errClinical and Translational Oncology
IF2.5
err2026-02-11
err0
PREAI
errSalih Tunbekici; Hamit Bal; Oguzcan Kınıkoglu; Hayati Arvas; Harun Muglu; Ahmet Bilici; Mustafa Seyyar; Halil Goksel Guzel; Banu Ozturk; Ozge Yalıcı; Duygu Ozaskın; Ramazan Cosar; Fatmagul Cıkladılmez; Evrican Zin; Aytac Terzi; Tugce Ulaslı; Taha Koray Sahın; Denız Can Guven; Gamze Serın; Merve Bıyıklı Alemdar; Bilgin Demir; Ali Kalem; Pervin Can; Kazım Uygun; Elif Sahin; Teoman Sakalar; Ali Kaan Guren; Gokhan Ozturk; Enes Yesılbas; Tugce Kubra Gunes; Burcu Belen; Muzaffer Ugraklı; Kursat Dıslı; Ahmet Oruc; Melek Karakurt Eryılmaz; Ismet Culcuoglu; Mustafa Ersoy; Bahadır Koylu; Fatih Selcukbiricik; Oguzhan Yıldız; Mehmet Emın Yılmaz; Saadettin Kılıckap; Ertugrul Bayram; Caner Acar; Gokhan Sahin; Haydar Cagatay Yuksel; Mustafa Murat Mıdık; Pınar Gursoy; Erdem Goker
err分享
err收藏
First-line lorlatinib treatment in a 19-year-old patient with ALK-rearranged pulmonary large-cell neuroendocrine carcinoma: a case report and literature review
errAnti-Cancer Drugs
IF2.2
err2026-01-01
err1
PREAI
errKemik, Fatih; Bulutay, Pinar; Kikili, Cevat Ilteris; Koylu, Bahadir; Demir, Nazan; Degirmenci, Elif; Ozer, Kadir Burak; Mericoz, Cisel Aydin; Tanju, Serhan; Selcukbiricik, Fatih
err分享
err收藏
Health-related quality of life and psychosocial outcomes in long-term survivors treated with immune checkpoint inhibitors: a nationwide multicenter study与健康相关的生活质量和免疫检查点抑制剂治疗长期存活者的心理社会结局：一项全国性多中心研究
errFrontiers in Immunology
IF5.9
err2025-12-10
err0
errOAAI
errTaha Koray Sahin; Fatih Atalah; Bahadir Koylu; Ahmet Oruc; Aydin Acarbay; Akgun Karakok; Sevgi Dogan; Cevat Ilteris Kikili; Görkem Turhan; Gamze Emin; Selahattin Celik; Ilknur Deliktas Onur; Tuba Ugur Tuzcu; Sedat Biter; Safa Can Efil; Fadime Sinem Ardic; Azer Gokmen; Halil Goksel Guzel; Kadri Turan; Ahmet Kürsad Disli; Salih Tunbekici; Erdem Goker; Mevlude Inanc; Ozlem Ozdemir; Banu Ozturk; Muslih Urun; Hatime Arzu Yasar; Mehmet Ali Nahit Sendur; Ismail Oguz Kara; Osman Sutcuoglu; Ozturk Ates; Tulay Eren; Atila Yildirim; Saadettin Kilickap; Omer Dizdar; Fatma Alev Turker; Mustafa Erman; Mehmet Artac; Fatih Selcukbiricik; Sercan Aksoy; Deniz Can Guven
err分享
err收藏
The Prognostic Impact of HER2 Status and Survival Outcomes in Metastatic Triple Negative Breast Cancer
errIN VIVO
IF1.8
err2025-11-01
err0
PREAI
errTurkel, Alper; Baydar, Ece; Colak, Rumeysa; Ozturk, Ahmet Emin; Sakalar, Teoman; Akbas, Sinem; Gur, Hasibe Bilge; Cavdar, Eyyup; Yilmaz, Mesut; Cabuk, Devrim; Selcukbiricik, Fatih; Hacibekiroglu, Ilhan; Dogan, Mutlu
err分享
err收藏
Avelumab maintenance in patients with metastatic urothelial carcinoma in a real-life expanded-access programavelumab维持治疗在真实世界扩展性准入计划中的转移性尿路上皮癌患者中的应用
errFuture Oncology
IF2.6
err2025-10-16
err0
PREAI
errDeniz Tural; Oğuzcan Özkan; Eda Eylemer Mocan; Caner Kapar; Sendag Yaslikaya; Ali Murat Tatlı; Goncagül Akdağ; Hacer Demir; Irem Bilgetekin; Fatih Selcukbiricik; Fatih Köse; Murat Sari; Gökmen Umut Erdem; Zehra Sucuoğlu İşleyen; Cagatay Arslan; Sinemis Celik; Türkkan Evrensel; Mustafa Erman; Seher Nazli Kazaz; Banu Ozturk; Halil Çelik; Miraç Özen; Pınar Erel; Pervin Can Şancı; Yaküp Ergün; Hakan Taban; Ömer Faruk Kuzu; Burcu Ulaş Kahya; Ahmet Melih Arslan; Abdullah Sakin; Murat Araz; Kerem Okutur; Fahri Akgül; Cem Mirili; Alper Sevinç; Fatih Atalah; Yakup Düzköprü; Burcu Gülbağcı; Serkan Yaşar; Nurten Kandemir; Hakan Kosku; Esra Aydın; Dilek Erdem; Murad Guliyev; Yaşar Çulha; Berksoy Şahin; Pınar Gürsoy; Yüksel Ürün
err分享
err收藏
AA amyloidosis as an adverse event of immune checkpoint inhibitor therapy: evidence from the FDA adverse event reporting system and a systematic reviewAA型淀粉样变性作为免疫检查点抑制剂治疗的 adverse event：来自FDA不良事件报告系统及系统综述的证据
errAMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS
IF7.4
err2025-10-01
err0
PREAI
errTopcu, Umur; Esen, Bugra Han; Bektas, Sevval Nur; Selcukbiricik, Fatih; Kanbay, Mehmet
err分享
err收藏
The mTOR pathway inhibition with everolimus in pseudomyogenic hemangioendothelioma harboring SERPINE1-FOSB gene fusion: a case report and review of the literature依维莫司抑制mTOR通路在含有SERPINE1-FOSB基因融合的假性血管肉瘤样血管内皮瘤中的应用：一例病例报告及文献综述
errANTI-CANCER DRUGS
IF2.2
err2025-10-01
err0
PREAI
errKikili, Cevat Ilteris; Koylu, Bahadir; Kemik, Fatih; Demir, Nazan; Deveci, Mehmet Ali; Selcukbiricik, Fatih
err分享
err收藏
Evaluating the Effectiveness of ChemoNurse: A Mobile Chemotherapy Drug Guide for Cancer Nurses – A Randomized Controlled Trial评估ChemoNurse移动化疗药物指南对癌症护士有效性的研究——一项随机对照试验
errEuropean Journal of Oncology Nursing
IF2.7
err2025-08-26
err0
PREAI
errRemziye Semerci Şahin; Arzu Tuna; Aslı Akdeniz Kudubeş; Esra Tayaz; Esra İbek; Enes Şimşek; Fatma Gündoğdu; İrem Yıldız Çilengiroğlu; Pınar Yılmaz; Fatih Selçukbiricik
err分享
err收藏
Impact of adding the immune checkpoint inhibitor atezolizumab to first-line chemotherapy on progression-free survival in poor-prognosis ovarian cancer: A retrospective analysis from the IMagyn050 trial在预后不良的卵巢癌中，添加免疫检查点抑制剂atezolizumab到一线化疗对无进展生存期的影响：IMagyn050试验的一项回顾性分析
errgynecologic oncology
IF4.1
err2025-06-01
err0
errOAAI
errYou, Benoit; Anderson, Charles; Cecere, Sabrina Chiara; Carrot, Aurore; Myers, Tashanna; Heitz, Florian; Sharma, Sudarshan; Selcukbiricik, Fatih; Aghajanian, Carol; Fernebro, Josefin; Blank, Stephanie; Laudani, Maria Elena; Thaker, Premal H.; Yunokawa, Mayu; Willmott, Lyndsay; Lisyanskaya, Alla; Hegg, Roberto; He, Yvette; Landen, Charles; Lin, Yvonne G.; Alarcon, Jesus; Moore, Kathleen N.
err分享
err收藏
The Clinical Outcomes and Safety of Sacituzumab Govitecan in Heavily Pretreated Metastatic Triple-Negative and HR+/HER2-Breast Cancer: A Multicenter Observational Study from TurkeySacituzumab Govitecan在重度预治疗转移性三阴性及HR+/HER2-乳腺癌中的临床疗效与安全性：一项来自土耳其的多中心观察性研究
errCANCERS
IF4.4
err2025-05-07
err0
errOAAI
errMuglu, Harun; Helvaci, Kaan; Koylu, Bahadir; Yucel, Mehmet Haluk; Celayir, Ozde Melisa; Demirci, Umut; Uluc, Basak Oyan; Basaran, Gul; Korkmaz, Taner; Selcukbiricik, Fatih; Olmez, Omer Fatih; Bilici, Ahmet
err分享
err收藏
What is the predictive value of pretreatment MRI characteristics for achieving a complete response after total neoadjuvant treatment in locally advanced rectal cancer?
errEUROPEAN JOURNAL OF RADIOLOGY
IF3.3
err2025-04-01
err0
PREAI
errKarahacioglu, Duygu; Atalay, Hande Ozen; Esmer, Rohat; Kabaoglu, Zeynep Unal; Senyurek, Sukran; Ozata, Ibrahim Halil; Taskin, Orhun cig; Saka, Burcu; Selcukbiricik, Fatih; Selek, Ugur; Rencuzogullari, Ahmet; Bugra, Dursun; Balik, Emre; Gurses, Bengi
err分享
err收藏
Pharmacovigilance analysis of immune checkpoint inhibitor-related reproductive adverse effects based on the FDA adverse event reporting system
errSCIENTIFIC REPORTS
IF3.9
err2025-03-05
err0
errOAAI
errKoylu, Bahadir; Esen, Bugra Han; Bektas, Sevval Nur; Ozbek, Lasin; Turan, Volkan; Urman, Bulent; Oktem, Ozgur; Selcukbiricik, Fatih
err分享
err收藏
Immune-related adverse events in older adults receiving immune checkpoint inhibitors: a comprehensive analysis of the Food and Drug Administration Adverse Event Reporting System接受免疫检查点抑制剂的老年人的免疫相关不良事件: 对美国食品和药物管理局不良事件报告系统的综合分析
errAGE AND AGEING
IF7.1
err2025-01-30
err1
errOAAI
errEsen, Bugra Han; Bektas, Sevval Nur; Topcu, Umur; Koylue, Bahadir; Kuvvet, Fadime Buket Bayram; Bahat, Gulistan; Selcukbiricik, Fatih
err分享
err收藏
Prognostic factors and outcomes of adjuvant and first-line metastatic treatments in melanoma a Turkish oncology group study黑色素瘤的辅助和一线转移治疗的预后因素和结果土耳其肿瘤学组研究
errSCIENTIFIC REPORTS
IF3.9
err2025-01-25
err0
errOAAI
errMajidova, Nargiz; Arak, Haci; Ozalp, Faruk Recep; Bas, Onur; Koker, Gulhan Ozcelik; Ozmarasali, Erkan Buket; Karateke, Yasemin Sagdic; Sakalar, Teoman; Yaslikaya, Sendag; Onur, Ilknur Deliktas; Akdag, Goncagul; Ogul, Ali; Guliyev, Murad; Sahin, Elif; Delipoyraz, Ebru Engin; Alkan, Ali; Aydin, Okan; Ilhan, Nurullah; Alan, Ozkan; Akbas, Sinem; Caglar, Yaprak; Guren, Ali Kaan; Sever, Nadiye; Ellez, Halil Ibrahim; Selcukbiricik, Fatih; Atci, Mustafa Muhammed; Bilici, Ahmet; Demirci, Nebi Serkan; Basoglu, Tugba; Karacin, Cengiz; Kara, Ismail Oguz; Yildiz, Bulent; Evrensel, Turkkan; Karaca, Mustafa; Dizdar, Omer; Atag, Elif; Ozgun, Alpaslan; Kostek, Osman
err分享
err收藏
Characterizing immune checkpoint inhibitor-related cutaneous adverse reactions: A comprehensive analysis of FDA adverse event reporting system (FAERS) database
errHELIYON
IF3.6
err2024-07-01
err3
errOAAI
errEsen, Bugra Han; Ozbek, Lasin; Oguz, Sinem; Selcukbiricik, Fatih
err分享
err收藏

研究方向

暂时未获取到该数据
合作学者
合作期刊
I
Ignace Vergote
H 指数: 135 · 论文数: 1.9K
I
Isabelle Ray‐Coquard
H 指数: 103 · 论文数: 1.1K
N
Nicoletta Colombo
H 指数: 102 · 论文数: 811
W
W. Glenn McCluggage
H 指数: 95 · 论文数: 749
J
Jalid Sehouli
H 指数: 95 · 论文数: 1.7K
查看更多